Clinical Trials Logo

Clinical Trial Summary

The induction dose of propofol is generally determined based on patients' characteristics, underlying disease, general condition, and also by clinician's experiences. However, It is difficult to anticipate and objectively calculate an adequate dose of propofol for every patient considering the variability of an individual's response to propofol. If there is a specific pattern in EEG prior to induction of anesthesia that can provide information about the patient's susceptibility to propofol, every induction may be performed far more smoothly with a precisely optimized dose of propofol for each patient. The study is to find a relationship between the pre-induction EEG pattern of adult patients and their sensitivity to propofol.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04520503
Study type Observational
Source Seoul National University Hospital
Contact
Status Completed
Phase
Start date September 9, 2020
Completion date February 28, 2022

See also
  Status Clinical Trial Phase
Completed NCT05158426 - Application of the Propofol Precise Infusion Model
Completed NCT02199522 - Clinical Observation of Titration Induction and Convention Induction of Propofol N/A
Completed NCT01435785 - Performance Evaluation of Four Pharmacokinetic-Pharmacodynamic(PKPD) Models of Propofol in Elderly Patients N/A